Bridgitte McIntosh Broxton, APRN-C

Bridgitte Broxton practices at Cleveland Clinic Florida - Weston in Weston, Florida.

Bridgitte Broxton's NPI, 1184057127, was assigned on August 13, 2013. Bridgitte Broxton holds Florida license APRN2049272.

Bridgitte Broxton's primary practice is Cleveland Clinic Florida - Weston, at 2950 Cleveland Clinic Blvd, Weston, FL 33331 in Broward County. The practice phone is (954) 659-6035.

Bridgitte Broxton's primary practice is Cleveland Clinic Florida - Weston in Weston, Florida. Bridgitte Broxton is also affiliated with Cleveland Clinic Weston Hospital. The medical group on file is Cleveland Clinic Florida. Dmand AI also links Bridgitte Broxton to 1 more hospital, 2 medical groups and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Bridgitte Broxton practices, 3 sites in all. Vendor and product names are available with a free account.

Nurse practitioner is Bridgitte Broxton's primary specialty in the NPI Registry, under taxonomy code 363L00000X. Bridgitte Broxton is board certified in family nurse practitioner by the American Academy of Nurse Practitioners Certification Program (AANPCP). Bridgitte Broxton is licensed in Florida.

Dmand AI lists chronic diabetes, diabetic emergency, enlarged thyroid, high cholesterol, osteoporosis and underactive thyroid among the conditions Bridgitte Broxton treats.

CMS data shows 2,337 Medicare services from Bridgitte Broxton across 9 procedure codes in 2024, for 336 Medicare patients. Medicare paid $78,923 for them. Every service was in an office.

CMS counts 336 Medicare patients who saw Bridgitte Broxton in 2024. The largest group is 65 to 74, with 144 patients. 75% of them have diabetes, and 75% have high blood pressure. 13% are also on Medicaid. Their average risk score is 2.07, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Bridgitte Broxton's median patient age at 63, with 54% women.

In 2024, Bridgitte Broxton wrote 4,687 Medicare Part D claims for 834 patients. 17% of them were for generic drugs. CMS names the drug for 4,432 of them, across 51 drugs with 11 or more claims each, at $2,283,178 in total drug cost.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 92 out of 100 for Bridgitte Broxton for performance year 2024, reported through an alternative payment model (APM). Bridgitte Broxton accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Bridgitte Broxton as offering telehealth.

CMS Open Payments shows 78 general payments to Bridgitte Broxton from 11 drug and device companies from 2024 to 2025. Food and beverage make up the largest share, 82% of the total. Medtronic, Inc. paid the most, $808.